ArticleJournal of veterinary internal medicine
Estimates of Urinary Calcium Excretion in Dogs With and Without Calcium Oxalate Urolithiasis.
Article in Journal of veterinary internal medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A novel missense variant in the calcium-sensing receptor gene in a dog with hypercalcemia.Journal of veterinary internal medicine · 2026Article
- Estimates of Urinary Calcium Excretion in Dogs With and Without Calcium Oxalate Urolithiasis.Journal of veterinary internal medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundFractional excretion of calcium (FeCa) and urine calcium-to-creatinine ratios (UCaCr) estimate hypercalciuria, but more data are needed on how well they discriminate between dogs with and without CaOx urolithiasis.
objectiveTo determine the performance of FeCa and UCaCr in predicting CaOx urolith status. ANIMALS: One hundred twenty-one client-owned, normocalcemic dogs: 42 CaOx stone formers (cases) and 79 controls.
methodsAnalytical, retrospective, cross-sectional study. FeCa (%) and UCaCr (mg/mg) were calculated using measurements from urine and blood and were compared by urolith status with Wilcoxon rank-sum tests. Performance was determined with receiver operating characteristic curves; "optimal" thresholds were selected to maximize sensitivity and specificity. Potential predictors of FeCa and UCaCr (e.g., urolith status, sex, breed, age) were modeled with multivariable regression. Spearman's rank correlation was run for FeCa and UCaCr.
resultsFeCa and UCaCr were greater in cases than controls (p < 0.001 for both); medians were 0.81 (0.12-2.47) and 0.060 (0.008-0.176) in cases and 0.50 (0.08-2.61) and 0.032 (0.005-0.131) in controls. Optimal thresholds for FeCa (0.56) and UCaCr (0.056) had moderate sensitivity (74% and 60%, respectively) and specificity (58% and 75%, respectively). FeCa and UCaCr were strongly correlated (rho = 0.94, p < 0.001) and lower in males than in females (estimate = -0.70 and -0.64, p = 0.002 and 0.005, respectively). CONCLUSIONS AND CLINICAL IMPORTANCE: FeCa or UCaCr perform moderately well for identifying CaOx cases; dogs with high values might benefit from therapy to reduce hypercalciuria. Their high correlation makes the determination of both unnecessary. Lower values in males support the development of sex-specific thresholds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.